Industry News: Dual-Targeted CAR T-cell Line Shows Promising Results in Preclinical Cancer Immunotherapy Study – SelectScience
SelectScience |
Industry News: Dual-Targeted CAR T-cell Line Shows Promising Results in Preclinical Cancer Immunotherapy Study
SelectScience “We aimed to overcome these challenges by demonstrating proof-of-concept for an off-the-shelf, dual-targeted CAR T-cell approach. We started with cells from a healthy donor rather than the patient, created a master cell line, and used the master cell … |
